Polymorphism of a pharmaceutical compound refers to its state of existing in different solid forms that is caused by the fact that the molecules of the compound, though being of the...

Related Keywords

China ,Yuanxia ,Jiangxi ,Japan ,Yongquan ,Sichuan ,Ying Zhang ,Zhejiang ,Jingyan ,Chinese ,Imatinib Mesylate ,Jingtai Technology Xtalpi ,Supreme People Court ,Patent Agency ,Crystalline Forms Of Pharmaceuticals ,Examining Inventive Step ,Crystalline Form ,Patent Examination ,Administrative Dispute ,Tiotropium Bromide ,Supreme People ,Patent Reexamination Board ,Several Stipulations ,Invention Patents ,Chemistry Field ,Invalidation Decision ,Patenting Crystalline ,Invalidation Case ,Invalid Decision ,Vortioxetine Hydrobromide ,Step Requirements ,Crystalline Forms ,Invalidation Cases ,Official Account ,Linda Liu ,Pharmaceutical Compounds ,Jingtai Technology ,Patent Grant ,Right Confirmation ,Determining Inventive Step ,